Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014, Article ID 235958, 4 pages
http://dx.doi.org/10.1155/2014/235958
Case Report

Ascites as the Presenting Symptom of Multiple Myeloma in a Scleroderma Patient

Department of Internal Medicine, Ain Wazein Hospital, P.O. Box 1503-2010/02, Ain Wazein, Lebanon

Received 30 August 2014; Accepted 4 November 2014; Published 20 November 2014

Academic Editor: James V. Dunne

Copyright © 2014 Nadeen Hilal and Adnan Atallah. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Medsger, “Systemic sclerosis (scleroderma): clinical aspects,” in Arthritis and Allied Conditions: A Textbook of Rheumatology, W. J. Koopman, Ed., pp. 1433–1465, Williams & Wilkins, Philadelphia, Pa, USA, 1997. View at Google Scholar
  2. N. Fett, “Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies,” Clinics in Dermatology, vol. 31, no. 4, pp. 432–437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. K. Rosenthal, J. K. McLaughlin, G. Gridley, and O. Nyren, “Incidence of cancer among patients with systemic sclerosis,” Cancer, vol. 76, pp. 910–914, 1995. View at Google Scholar
  4. M. Abu-Shakra, F. Guillemin, and P. Lee, “Cancer in systemic sclerosis,” Arthritis and Rheumatism, vol. 36, no. 4, pp. 460–464, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. Duncan and R. K. Winkelmann, “Cancer and scleroderma,” Archives of Dermatology, vol. 115, no. 8, pp. 950–955, 1979. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Olesen, C. Sværke, D. K. Farkas, and H. T. Sørensen, “Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study,” British Journal of Dermatology, vol. 163, no. 4, pp. 800–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. T. Derk, M. Rasheed, C. M. Artlett, and S. A. Jimenez, “A cohort study of cancer incidence in systemic sclerosis,” Journal of Rheumatology, vol. 33, no. 6, pp. 1113–1116, 2006. View at Google Scholar · View at Scopus
  8. K. Y. Kang, H. W. Yim, I. J. Kim et al., “Incidence of cancer among patients with systemic sclerosis in Korea results from a single centre,” Scandinavian Journal of Rheumatology, vol. 38, no. 4, pp. 299–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Onishi, D. Sugiyama, S. Kumagai, and A. Morinobu, “Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies,” Arthritis and Rheumatism, vol. 65, no. 7, pp. 1913–1921, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Chatterjee, G. W. Dombi, R. K. Severson, and M. D. Mayes, “Risk of malignancy in scleroderma: a population-based cohort study,” Arthritis and Rheumatism, vol. 52, no. 8, pp. 2415–2424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Thomas, D. H. Brewster, R. J. Black, and G. J. Macfarlane, “Risk of malignancy among patients with rheumatic conditions,” International Journal of Cancer, vol. 88, no. 3, pp. 497–502, 2000. View at Google Scholar
  12. R. A. Kyle and S. V. Rajkumar, “Drug therapy: multiple myeloma,” The New England Journal of Medicine, vol. 351, no. 18, pp. 1860–1921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Kyle and S. V. Rajkumar, The New England Journal of Medicine, vol. 352, p. 1163, 2005.
  14. L. M. Brown, G. Gridley, D. Check, and O. Landgren, “Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders,” Blood, vol. 111, no. 7, pp. 3388–3394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Hemminki, X. Liu, A. Forsti, J. Ji, J. Sundquist, and K. Sundquist, “Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma,” Journal of Hematology and Oncology, vol. 5, article 59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Čolović, V. Jurisic, J. Bila, N. Čolović, and V. Palibrk, “FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature,” International Journal of Hematology, vol. 93, no. 2, pp. 228–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Santos-Juanes, C. Galache Osuna, J. R. Curto Iglesias, J. F. B. De Quiros, and J. Sánchez Del Río, “Treatment with chemotherapy of scleredema associated with Ig A myeloma,” International Journal of Dermatology, vol. 40, no. 11, pp. 720–721, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Casper, P. Scharffetter-Kochanek, H. Bohlen, R. P. Linke, T. Krieg, and N. Hunzelmann, “Light chain multiple myeloma with peripheral leucocytosis presenting as scleroderma amyloidosum of the Aλ-type,” British Journal of Dermatology, vol. 140, no. 6, pp. 1172–1174, 1999. View at Google Scholar · View at Scopus
  19. C. Paredes-Suárez, V. Fernández-Redondo, M. Vázquez Blanco, D. Sánchez-Aguilar, and J. Toribio, “Multiple myeloma with scleroderma-like changes,” Journal of the European Academy of Dermatology and Venereology, vol. 19, no. 4, pp. 500–502, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Manley, J. Monteath, and W. N. Patton, “Co-incidental presentation of IgA lambda multiple myeloma and pleural involvement with IgM kappa non-Hodgkin's lymphoma,” Clinical and Laboratory Haematology, vol. 21, no. 1, pp. 61–63, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. R. L. Sasser, L. T. Yam, and C.-Y. Li, “Myeloma with involvement of the serous cavities. Cytologic and immunochemical diagnosis and literature review,” Acta Cytologica, vol. 34, no. 4, pp. 479–485, 1990. View at Google Scholar · View at Scopus
  22. P. Young, B. B. Finn, D. Pellegrini et al., “Myelomatous ascites,” Anales de Medicina Interna, vol. 25, no. 2, pp. 85–89, 2008. View at Google Scholar · View at Scopus